The University of Chicago Header Logo

Connection

Royce Lee to Male

Back to Details
This is a "connection" page, showing publications Royce Lee has written about Male.
Royce Lee
Connection Strength
0.903
Male
  1. Disordered Aggression and Violence in the United States. J Clin Psychiatry. 2020 03 17; 81(2).
    View in: PubMed
    Score: 0.037
  2. Narcissistic and Borderline Personality Disorders: Relationship With Oxidative Stress. J Pers Disord. 2020 03; 34(Suppl):6-24.
    View in: PubMed
    Score: 0.036
  3. 5-HT2c agonist, lorcaserin, reduces aggressive responding in intermittent explosive disorder: A pilot study. Hum Psychopharmacol. 2019 11; 34(6):e2714.
    View in: PubMed
    Score: 0.036
  4. Comorbidity of personality disorder with intermittent explosive disorder. J Psychiatr Res. 2018 11; 106:15-21.
    View in: PubMed
    Score: 0.033
  5. Circulating endocannabinoids and affect regulation in human subjects. Psychoneuroendocrinology. 2018 06; 92:66-71.
    View in: PubMed
    Score: 0.032
  6. Intermittent Explosive Disorder and Substance Use Disorder: Analysis of the National Comorbidity Survey Replication Sample. J Clin Psychiatry. 2017 Jun; 78(6):697-702.
    View in: PubMed
    Score: 0.030
  7. Social emotional information processing in adults: Development and psychometrics of a computerized video assessment in healthy controls and aggressive individuals. Psychiatry Res. 2017 Feb; 248:40-47.
    View in: PubMed
    Score: 0.029
  8. Social cognition in Intermittent Explosive Disorder and aggression. J Psychiatr Res. 2016 12; 83:140-150.
    View in: PubMed
    Score: 0.028
  9. Development of a social emotional information processing assessment for adults (SEIP-Q). Aggress Behav. 2017 Jan; 43(1):47-59.
    View in: PubMed
    Score: 0.028
  10. Substance use disorders: Relationship with intermittent explosive disorder and with aggression, anger, and impulsivity. J Psychiatr Res. 2016 10; 81:127-32.
    View in: PubMed
    Score: 0.028
  11. White Matter Integrity Reductions in Intermittent Explosive Disorder. Neuropsychopharmacology. 2016 10; 41(11):2697-703.
    View in: PubMed
    Score: 0.028
  12. GH response to intravenous clonidine challenge correlates with history of childhood trauma in personality disorder. J Psychiatr Res. 2016 May; 76:38-43.
    View in: PubMed
    Score: 0.027
  13. Emotional intelligence and impulsive aggression in Intermittent Explosive Disorder. J Psychiatr Res. 2015 Feb; 61:135-40.
    View in: PubMed
    Score: 0.025
  14. Intermittent Explosive Disorder and aversive parental care. Psychiatry Res. 2014 Dec 15; 220(1-2):477-82.
    View in: PubMed
    Score: 0.025
  15. Modulation of central serotonin affects emotional information processing in impulsive aggressive personality disorder. J Clin Psychopharmacol. 2012 Jun; 32(3):329-35.
    View in: PubMed
    Score: 0.021
  16. Cerebrospinal fluid 5-hydroxyindolacetic acid correlates directly with negative affective intensity, but not affective lability, in human subjects. Int J Neuropsychopharmacol. 2013 Mar; 16(2):261-9.
    View in: PubMed
    Score: 0.021
  17. The neuroendocrinology of childhood trauma in personality disorder. Psychoneuroendocrinology. 2012 Jan; 37(1):78-86.
    View in: PubMed
    Score: 0.020
  18. Growth hormone responses to GABAB receptor challenge with baclofen and impulsivity in healthy control and personality disorder subjects. Psychopharmacology (Berl). 2011 May; 215(1):41-8.
    View in: PubMed
    Score: 0.019
  19. Plasma homovanillic acid correlates inversely with history of childhood trauma in personality disordered and healthy control adults. J Neural Transm (Vienna). 2010 Nov; 117(11):1327-34.
    View in: PubMed
    Score: 0.019
  20. Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: reciprocal relationships with impulsive aggression in human subjects. J Neural Transm (Vienna). 2010 Feb; 117(2):241-8.
    View in: PubMed
    Score: 0.018
  21. Cerebrospinal fluid oxytocin, life history of aggression, and personality disorder. Psychoneuroendocrinology. 2009 Nov; 34(10):1567-73.
    View in: PubMed
    Score: 0.017
  22. Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers. Int Clin Psychopharmacol. 2008 Nov; 23(6):337-41.
    View in: PubMed
    Score: 0.017
  23. Cerebrospinal fluid GABA concentration: relationship with impulsivity and history of suicidal behavior, but not aggression, in human subjects. J Psychiatr Res. 2009 Jan; 43(4):353-9.
    View in: PubMed
    Score: 0.016
  24. CSF corticotropin-releasing factor in personality disorder: relationship with self-reported parental care. Neuropsychopharmacology. 2006 Oct; 31(10):2289-95.
    View in: PubMed
    Score: 0.014
  25. Childhood trauma and personality disorder: positive correlation with adult CSF corticotropin-releasing factor concentrations. Am J Psychiatry. 2005 May; 162(5):995-7.
    View in: PubMed
    Score: 0.013
  26. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. Psychiatry Res. 2003 May 30; 118(2):129-36.
    View in: PubMed
    Score: 0.011
  27. Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC. Neuropsychopharmacology. 2022 06; 47(7):1331-1338.
    View in: PubMed
    Score: 0.010
  28. Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults. Psychopharmacology (Berl). 2022 Jun; 239(6):1735-1747.
    View in: PubMed
    Score: 0.010
  29. Effects of Intranasal Oxytocin on Stress-Induced Cigarette Craving in Daily Smokers. Nicotine Tob Res. 2020 01 27; 22(1):89-95.
    View in: PubMed
    Score: 0.009
  30. Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 04; 5(4):461-467.
    View in: PubMed
    Score: 0.009
  31. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers. Biol Psychiatry. 2019 11 15; 86(10):792-800.
    View in: PubMed
    Score: 0.009
  32. Oxytocin Reduces Cigarette Consumption in Daily Smokers. Nicotine Tob Res. 2019 05 21; 21(6):799-804.
    View in: PubMed
    Score: 0.009
  33. Subtypes of aggression in intermittent explosive disorder. J Psychiatr Res. 2019 02; 109:164-172.
    View in: PubMed
    Score: 0.008
  34. Social desirability, deceptive reporting, and awareness of problematic aggression in intermittent explosive disorder compared with non-aggressive healthy and psychiatric controls. Psychiatry Res. 2018 12; 270:20-25.
    View in: PubMed
    Score: 0.008
  35. Intranasal Oxytocin Does Not Modulate Responses to Alcohol in Social Drinkers. Alcohol Clin Exp Res. 2018 09; 42(9):1725-1734.
    View in: PubMed
    Score: 0.008
  36. Reduced frontal grey matter, life history of aggression, and underlying genetic influence. Psychiatry Res Neuroimaging. 2018 01 30; 271:126-134.
    View in: PubMed
    Score: 0.008
  37. Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: a pilot study. Behav Pharmacol. 2016 12; 27(8):697-703.
    View in: PubMed
    Score: 0.007
  38. Differential fMRI BOLD responses in amygdala in intermittent explosive disorder as a function of past Alcohol Use Disorder. Psychiatry Res Neuroimaging. 2016 Nov 30; 257:5-10.
    View in: PubMed
    Score: 0.007
  39. Comorbid intermittent explosive disorder and posttraumatic stress disorder: Clinical correlates and relationship to suicidal behavior. Compr Psychiatry. 2016 10; 70:125-33.
    View in: PubMed
    Score: 0.007
  40. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects. Psychoneuroendocrinology. 2016 09; 71:189-96.
    View in: PubMed
    Score: 0.007
  41. Toxoplasma gondii infection: relationship with aggression in psychiatric subjects. J Clin Psychiatry. 2016 Mar; 77(3):334-41.
    View in: PubMed
    Score: 0.007
  42. Childhood trauma and parental style: Relationship with markers of inflammation, oxidative stress, and aggression in healthy and personality disordered subjects. Biol Psychol. 2015 Dec; 112:56-65.
    View in: PubMed
    Score: 0.007
  43. Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder. Psychiatry Res. 2015 Oct 30; 229(3):844-9.
    View in: PubMed
    Score: 0.007
  44. Morphometric analysis of amygdla and hippocampus shape in impulsively aggressive and healthy control subjects. J Psychiatr Res. 2015 Oct; 69:80-6.
    View in: PubMed
    Score: 0.007
  45. Effects of Escitalopram Administration on Face Processing in Intermittent Explosive Disorder: An fMRI Study. Neuropsychopharmacology. 2016 Jan; 41(2):590-7.
    View in: PubMed
    Score: 0.007
  46. Cerebrospinal fluid inflammatory cytokines and aggression in personality disordered subjects. Int J Neuropsychopharmacol. 2015 Feb 03; 18(7):pyv001.
    View in: PubMed
    Score: 0.006
  47. Cerebrospinal fluid and plasma C-reactive protein and aggression in personality-disordered subjects: a pilot study. J Neural Transm (Vienna). 2015 Feb; 122(2):321-6.
    View in: PubMed
    Score: 0.006
  48. History of childhood maltreatment in intermittent explosive disorder and suicidal behavior. J Psychiatr Res. 2014 Sep; 56:10-7.
    View in: PubMed
    Score: 0.006
  49. Relationship between psychopathy, aggression, anger, impulsivity, and intermittent explosive disorder. Aggress Behav. 2014 Nov-Dec; 40(6):526-36.
    View in: PubMed
    Score: 0.006
  50. Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocrinology. 2014 Aug; 46:23-31.
    View in: PubMed
    Score: 0.006
  51. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry. 2014 Feb; 71(2):158-65.
    View in: PubMed
    Score: 0.006
  52. Elevated Plasma Oxidative Stress Markers in Individuals With Intermittent Explosive Disorder and Correlation With Aggression in Humans. Biol Psychiatry. 2016 Jan 15; 79(2):127-35.
    View in: PubMed
    Score: 0.006
  53. Effects of MDMA and Intranasal oxytocin on social and emotional processing. Neuropsychopharmacology. 2014 Jun; 39(7):1654-63.
    View in: PubMed
    Score: 0.006
  54. Validity of the new A1 and A2 criteria for DSM-5 intermittent explosive disorder. Compr Psychiatry. 2014 Feb; 55(2):260-7.
    View in: PubMed
    Score: 0.006
  55. Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects. J Psychiatr Res. 2013 Sep; 47(9):1247-53.
    View in: PubMed
    Score: 0.006
  56. Cerebrospinal fluid neuropeptide Y-like immunoreactivity correlates with impulsive aggression in human subjects. Biol Psychiatry. 2012 Dec 15; 72(12):997-1003.
    View in: PubMed
    Score: 0.005
  57. Cerebrospinal fluid substance P-like immunoreactivity correlates with aggression in personality disordered subjects. Biol Psychiatry. 2012 Aug 01; 72(3):238-43.
    View in: PubMed
    Score: 0.005
  58. Moderating effects of childhood maltreatment on associations between social information processing and adult aggression. Psychol Med. 2012 Jun; 42(6):1293-304.
    View in: PubMed
    Score: 0.005
  59. Inter-relationship between different platelet measures of 5-HT and their relationship to aggression in human subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30; 36(2):277-81.
    View in: PubMed
    Score: 0.005
  60. Personality predictors of antiaggressive response to fluoxetine: inverse association with neuroticism and harm avoidance. Int Clin Psychopharmacol. 2011 Sep; 26(5):278-83.
    View in: PubMed
    Score: 0.005
  61. Cortisol responses to ipsapirone challenge correlate with aggression, while basal cortisol levels correlate with impulsivity, in personality disorder and healthy volunteer subjects. J Psychiatr Res. 2010 Oct; 44(14):874-80.
    View in: PubMed
    Score: 0.005
  62. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects. Neuropsychopharmacology. 2010 Jan; 35(2):435-44.
    View in: PubMed
    Score: 0.005
  63. Indices of orbitofrontal and prefrontal function in Cluster B and Cluster C personality disorders. Psychiatry Res. 2009 Dec 30; 170(2-3):282-5.
    View in: PubMed
    Score: 0.004
  64. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder. J Psychiatr Res. 2010 Feb; 44(3):137-42.
    View in: PubMed
    Score: 0.004
  65. A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. J Clin Psychiatry. 2009 Apr 21; 70(5):653-62.
    View in: PubMed
    Score: 0.004
  66. Acute tryptophan depletion and self-injurious behavior in aggressive patients and healthy volunteers. Psychopharmacology (Berl). 2009 Mar; 203(1):53-61.
    View in: PubMed
    Score: 0.004
  67. Prevalence of suicidal and self-injurious behavior among subjects with intermittent explosive disorder. Psychiatry Res. 2008 Mar 15; 158(2):248-50.
    View in: PubMed
    Score: 0.004
  68. The relationship between impulsive verbal aggression and intermittent explosive disorder. Aggress Behav. 2008 Jan-Feb; 34(1):51-60.
    View in: PubMed
    Score: 0.004
  69. Norepinephrine function in personality disorder: plasma free MHPG correlates inversely with life history of aggression. CNS Spectr. 2003 Oct; 8(10):731-6.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.